Anzeige
Mehr »
Mittwoch, 13.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P4CC | ISIN: US19624Y2000 | Ticker-Symbol: CBH
Siehe auch COLOPLAST A/S
München
13.08.25 | 08:03
8,150 Euro
0,00 % 0,000
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
COLOPLAST A/S ADR Chart 1 Jahr
5-Tage-Chart
COLOPLAST A/S ADR 5-Tage-Chart

Aktuelle News zur COLOPLAST A/S ADR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
03.06.Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 202548
20.05.Coloplast senkt Prognose - Konzernchef muss gehen273
15.05.HSBC cuts Coloplast stock rating, lowers price target to DKK67059
09.05.RBC Capital cuts Coloplast stock rating, lowers price target47
08.05.Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons41
COLOPLAST A/S ADR Aktie jetzt für 0€ handeln
07.05.Barclays cuts Coloplast stock rating, lowers price target87
06.05.Coloplast Finance B.V.: Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/2539
06.05.Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25851Interim financial results, H1 2024/25 1 October 2024 - 31 March 2025 Coloplast delivered 6% organic growth in Q2, impacted by the product recall in Interventional Urology and a softer quarter in...
► Artikel lesen
05.05.Coloplast A/S CEO Kristian Villumsen steps down as of today754Coloplast CEO Kristian Villumsen steps down from his CEO position as of today. The Board of Directors has asked Lars Rasmussen to step in as interim CEO. As the company is entering into a new strategy...
► Artikel lesen
05.05.Coloplast stock rating cut, target slashed by Deutsche Bank60
01.05.Coloplast A/S Revised guidance for FY 2024/25635Coloplast revises financial guidance for FY 2024/25 and pre-announces H1 2024/25 key financial figures Coloplast revises the guidance on organic growth and EBIT margin before special items for FY...
► Artikel lesen
14.03.Coloplast Finance B.V. - Decisions at the Annual General Meeting40
13.03.JPMorgan raises Coloplast stock rating to Neutral, sets DKK700 target46
03.03.Coloplast upgraded to 'outperform' as RBC sees strong upside potential92
03.03.RBC Capital lifts Coloplast stock rating, raises target to DKK94016
04.02.Coloplast Finance B.V. - Interim Financial Report, Q1 2024/256102024/25 Interim financial results, Q1 2024/25 1 October 2024 - 31 December 2024 Coloplast delivered 8% organic growth and an EBIT margin1 of 27% in Q1, in line with expectations. Reported revenue...
► Artikel lesen
04.02.Coloplast A/S - Interim Financial Report, Q1 2024/254372024/25 Interim financial results, Q1 2024/25 1 October 2024 - 31 December 2024 Coloplast delivered 8% organic growth and an EBIT margin1 of 27% in Q1, in line with expectations. Reported revenue...
► Artikel lesen
09.12.24Dividendenbekanntmachungen (09.12.2024)11.963 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ALMACENES EXITO SA ADR  US02028M1053  0,0353 USD  0,0334 EUR  ALPHABET INC CDR  CA02080K1049  0,0331 CAD  0,0221 EUR  ALPHABET INC CL A  US02079K3059  0...
► Artikel lesen
05.12.24Coloplast A/S - Decisions at the Annual General Meeting 2024357Today, 5 December 2024, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted: The annual report for the financial year 2023/24 was approved.Distribution of...
► Artikel lesen
04.12.24Coloplast A/S: Coloplast divests core Skin Care product portfolio439The divestment is part of a strategic initiative to simplify business operations and improve profitability in the Advanced Wound Care business area. Revenue from the core Skin Care business amounted...
► Artikel lesen
Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1